Cycurion is trading 5.26% down in pre-market at $0.58, as continued investor concern surrounds its Nasdaq delisting process.
- The Nasdaq hearing is scheduled for August 20, 2026; the company remains listed pending the Panel’s decision.
- Recent warrant-inducement financing generated approximately $4.5 million and included warrants representing 150% of exercised warrants, increasing dilution concerns.
- Broader markets are relatively steady, making company-specific risks the primary explanation.